Page 63 - boneArtis Seminare - Catalog

Synthacer® / Syntricer® Bone Void Filler
Synthacer® and Syntricer® are indicated for the treat- ment of surgical bone defects or defects of another pathogenesis:
- Bone void lling of defects caused by traumata
- Filling of bone voids a er gathering of autologous cancellous bone, i.e. the iliac crest or donor defects in the trochlea patellae or other donor regions.
- Bone void lling and augmentation in maxilla-facial surgery.
“Clinical evidence con rms the following product prop- erties”:
- Bone void lling
- Osteoconduction
- Radiopaque material - Biocompatibility
- Purity of the material.
Only Syntricer®:
- nearly complete biodegradation within 3 – 4 months
depending upon the turn-over rate
Only Synthacer®:
- slow (insigni cant) biodegradation
Up until today, no interaction between Syntricer® and Synthacer® products and drugs or other medical devices has been observed, with the exception of the direct com- bination with sti implants.
Synthacer®/Syntricer® is therefore used in Traumatology, Orthopaedic Surgery, Reconstructive Surgery, Maxillo- Facial Surgery and Oto-Rhino-Laryngology, i.e. for re- construction of the “mastoid process”.
e material is used in all kinds of bone defects where shear, tension as well as torsion and high compressive forces can be ignored. “Ceramic disease”, caused by rela- tive micro-movements of the ceramic particles or by sti implants (screws, metal implants etc.), can be avoided with a combination of materials providing damping properties, i.e. morsellized bone preferably of the same size or by a recipient bed with an intact cancellous bone environment. is results in the so-called
REV0118122017EN 63